Combination of Novoseven and Feiba in Hemophiliac Patients with Inhibitors

The aim of this study is to investigate the effective therapeutic combination of recombinant VIIa(Novoseven) and factor eight inhibitor bypass activity(FEIBA) drugs for the bleedings of adult hemophiliac patients with inhibitors.19 bleeding episodes of 5 hemophilia A patients who were using bypassin...

Descripción completa

Detalles Bibliográficos
Autores principales: Malkan, Umit Yavuz, Aksu, Salih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2018
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310920/
https://www.ncbi.nlm.nih.gov/pubmed/30613789
http://dx.doi.org/10.1515/med-2018-0090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310920/
https://www.ncbi.nlm.nih.gov/pubmed/30613789
http://dx.doi.org/10.1515/med-2018-0090

Ejemplares similares